Edition:
United States

Aimmune Therapeutics Inc (AIMT.OQ)

AIMT.OQ on NASDAQ Stock Exchange Global Select Market

33.60USD
12 Dec 2017
Change (% chg)

-- (--)
Prev Close
$33.60
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
140,083
52-wk High
$38.86
52-wk Low
$15.97

Get access to over 18 million research reports from over 1,700 sources.

For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.

Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.

Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:

  • ownership
  • filings
  • deals
  • private equity
  • third-party document and information retrieval
  • estimates
  • fundamentals
  • economics
  • events
  • news
  • and much, much more…

Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.

Name Age Since Current Position

Mark McDade

61 2015 Independent Chairman of the Board

Stephen Dilly

57 2016 President, Chief Executive Officer, Director

Eric Bjerkholt

57 2017 Chief Financial Officer

Jeffrey Knapp

51 2016 Chief Operating Officer

Susan Barrowcliffe

59 2016 Senior Vice President, General Manager of Europe